HomeAI · summaries
Storia in 2 fonti
Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Dr Reddy’s gets USFDA nod for rituximab biosimilar
Dr. Reddy’s Laboratories gains USFDA approval for rituximab biosimilar, enhancing its global biosimilars portfolio and market presence.
- ·
morningstar.com
Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market